Lee's Pharmaceutical (00950) said its profit attributable to the equity shareholders for the three months ended 30 September 2014 rose 30.7% year-on-year to HK$49.47 million.
Its basic and diluted earnings per share were HK9.1 cents and HK8.92 cents.
The turnover was HK$247 million, an increase of 39% from a year earlier.
For the first nine months of 2014, net profit grew 22.3% year-on-year to HK$137 million and turnover rose 34.6% to HK$689 million.
Gross profit margin for the third quarter was 69.2%, a slight decrease of 0.1 percentage point over the second quarter this year. Gross profit margin for the nine months ended 30 September 2014 was 70%, a decrease of 1.7 percentage point over same period last year. As production in Hefei has transited into optimal phase, the lower gross margin observed in the third quarter was the result of increasing revenue from licensed-in product that normally has higher cost of goods.
etnet榮獲HKEX Awards 2023 「最佳表現證券數據供應商」大獎► 了解詳情
